![1]()
News
Case series suggests biologics, JAK inhibitors safe during pandemic
May 1, 2020
Investigators saw no increase in hospitalizations versus the general population in New York City.
News
Antitumor treatment may increase risk of severe events in COVID-19 patients
May 1, 2020
Receiving antitumor treatment within 14 days of COVID-19 diagnosis was linked to a higher risk of ICU admission, mechanical ventilation, or death.
News
Yale’s COVID-19 inpatient protocol: Hydroxychloroquine plus/minus tocilizumab
April 30, 2020
Yale cardiologist offers lessons from “the haze of battle” on fighting COVID-19 with little evidence.
![1]()
News
POPCoRN network mobilizes pediatric capacity during pandemic
April 30, 2020
The Pediatric Overflow Planning Contingency Response Network has worked like medical crowd sourcing.
![1]()
News
Predictors of ICH after thrombectomy identified
April 30, 2020
The sum of three variables may predict which patients undergoing thrombectomy up to 24 hours after a stroke are at higher risk of developing symptomatic intracranial hemorrhage.
![1]()
News
IDSA guidelines cover N95 use and reuse
April 30, 2020
The Infectious Disease Society of America released guidelines for personal protective equipment use by health care workers caring for COVID-19 patients.
![1]()
News
New tetracycline antibiotic effective in community-acquired bacterial pneumonia
April 30, 2020
Is omadacycline, a new tetracycline-class antibiotic, as effective as moxifloxacin in the treatment of community-acquired bacterial pneumonia?
![1]()
News
COVID-19: An opportunity, challenge for addiction treatment, NIDA boss says
April 30, 2020
Right now, said Dr. Nora Volkow, “we are in the dark as to how COVID infections have affected the number of overdose deaths.”
News
Trials and tribulations: Neurology research during COVID-19
April 30, 2020
Many researchers have redesigned their studies, at least in part to optimize the safety of their participants and research staff.
News
Remdesivir now ‘standard of care’ for COVID-19, Fauci says
April 30, 2020
The interim results show that time to recovery was 31% faster for patients who received remdesivir than for those who received placebo.
